Pharmaceutical Ingredients Program

About DoubleRainbow Biosciences

DoubleRainbow Biosciences, founded in 2016 and based in San Diego, is a private biotechnology company leveraging synthetic biology to address supply chain and sustainability challenges in natural product manufacturing. The company's core technology, the PRISM enzyme modification platform, is designed to glycosylate medicinal compounds to improve their solubility, potency, and efficacy. DoubleRainbow aims to create sustainable therapeutics, nutraceuticals, and agricultural solutions, positioning itself at the intersection of human health and environmental stewardship. It operates as a platform company and is currently in a pre-revenue, pre-clinical stage of development.